As expected, six out of eight mice that received 10 000 AE9a‐Ddit4+/+GFP+ cells developed leukemia with a mortality of 75%, while the mortality of mice receiving 10 000 AE9a‐Ddit4−/− GFP+ leukemic cells was only 12.5%. Here, DDIT4 is linked to leukemia.